200HO11586 EINSTEIN

Registration Name SILVERRIDGE V EINSTEIN-ET
Registration Number HOCAN000012857528
Primary NAAB Code 200HO11586
Secondary Code(s) 777HO11586, 517HO11586, 518HO11586, 722HO11586, 723HO11586
Status Active AI Sire
Controller Name Semex Alliance (200)
Date of Birth 4/18/2018
aAa 534126
DMS 345
GFI 13.3%
Genetic Codes * TD TY TL TV TR TP TC TE
Haplotypes HH1T, HH2C, HH3T, HH4T, HH5T, HH6T
Beta Casein A2A2
Kappa Casein AB
Beta Lactoglobulin -
INDEXES
NM$ 584, 92% R CM$ 616
NM Percentile 59% FM$ 513
GTPI 3203 GM$ 574
PRODUCTION TRAITS
6748 Dtrs 1084 herds 39 % US 99% R
Milk 777 Fat, % 73 , +0.15%
SCS 2.71, 99% R Protein, % 42 , +0.06%
Feed Saved -320 , 58% R Milking Speed 6.78 , 95% R
Health & Fertility
Productive Life 3.3      99% R Mastitis 1.8      96% R
Heifer Livability -0.1       89% R Metritis 1.1      92% R
Livability 0.6      93% R D. Abom -0.3      95% R
DPR 1.5      99% R Ketosis 1.2      90% R
FSC 7.3      99% R R. Placenta 1.0      93% R
HCR 1.5      97% R Milk Fever -0.2      83% R
CCR 3.2      99% R
SCR 1.8      96% R
DIA -0.3      79% R
RSP -2.9      86% R
Calving Traits
Sire CE 1.4      99% R 8716 Obs
Daughter CE 1.7      97% R 2206 Obs, 3061 Dtrs
Sire SB 4.2      97% R 9990 Obs
Daughter SB 4.5      97% R 2158 Obs, Dtrs
Gestation Length -1.1      99% R 402 Obs, 6393 Dtrs
Early First Calving 2.8      98% R 259 Obs, 2414 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
2991 Dtrs 634 herds 99% R
PTA Type 0.61 UDC 1.15
HCC 1.03 BWC 1.02
FLC -0.57
Linear Traits
Stature -0.03
Short
Strength 0.97
Weak
Body Depth 0.55
Deep
Dairy Form 0.03
Open
Rump Angle 0.20
Sloped
Thurl Width 1.76
Sloped
Rear Legs-Side View 1.76
Wide
Rear Legs-Rear View -1.00
H.-in
Foot Angle 0.04
Steep
Feet & Legs Score -0.36
Low
F.U. Attachment -1.79
Straight
Rear Udder Height 1.09
High
Rear Udder Width 2.51
Wide
Udder Cleft 1.85
Strong
Udder Depth -1.00
H.-in
Front Teat Placement 1.06
Close
Rear Teat Placement 1.55
Close
Teat Length 0.66
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO